EIF4A3 and neoplasm: LINC01016 blocks the binding of EIF4A3 to MMP9 mRNA, thereby inhibiting EIF4A3-mediated NMD, leading to increased MMP9 mRNA and protein expression, and promoting tumor progression (Fig. 6J).